Yahoo Web Search

  1. Ads

    related to: software development company profile

Search results

    • Sarepta Therapeutics (NASDAQ:SRPT) PT Raised to $179.00

      ETF DAILY NEWS· 3 days ago

      :SRPT – Get Free Report) had its target price hoisted by Mizuho from $145.00 to $179.00 in a report issued on Friday, Benzinga reports. The firm presently has a “buy” rating on the biotechnology ...

  1. Ad

    related to: software development company profile